GlassScriptPhysician profile
Paulami Guha
NPI 1912260613
$6,100.09
in general payments reported to CMS, 2019-2025
39 companies · $2,083 in 2025
The $2,083 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $257 · 2021: $1,483 · 2022: $554 · 2023: $568 · 2024: $375 · 2025: $2,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600 · Food and Beverage: $1,342 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
| Food and Beverage | $1,341.60 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,752.87 | 2019-2025 | |
| Acessa Health INC. | $993.51 | 2021 | |
| Abbvie INC. | $524.14 | 2019-2023 | |
| Hologic Sales and Service, LLC | $230.42 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Intuitive Surgical, INC. | $209.69 | 2020-2025 | |
| Astellas Pharma US INC | $209.42 | 2022-2025 | Veozah |
| Novo Nordisk INC | $208.18 | 2021-2023 | Wegovy, Saxenda |
| Pfizer INC. | $166.70 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $158.87 | 2022-2025 | |
| Myovant Sciences INC. | $152.72 | 2022 | |
| Shield Therapeutics INC | $151.34 | 2023-2025 | Accrufer |
| Lupin INC. | $149.87 | 2019 | |
| Millicent US INC | $136.30 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Exeltis, USA INC. | $110.26 | 2021-2025 | Slynd |
| Aspira Women'S Health INC | $106.63 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $94.74 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $87.24 | 2019-2020 | |
| Mycovia Pharmaceuticals, INC. | $49.71 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $47.09 | 2020-2023 | Bridion |
| Therapeuticsmd, INC. | $43.76 | 2019-2022 | |
| Applied Medical Resources Corporation | $43.00 | 2020 | |
| Evofem Biosciences, INC. | $41.97 | 2021-2022 | |
| Scynexis, INC. | $41.03 | 2022 | |
| Aesculap, INC. | $40.42 | 2019 | |
| Mallinckrodt Enterprises LLC | $38.16 | 2019 | |
| Olympus America INC. | $35.81 | 2019 | |
| Covidien LP | $33.74 | 2019 | |
| Lsi Solutions INC | $29.45 | 2024 | Fornisee |
| Coopersurgical, INC. | $28.28 | 2025 | Paragard T 380a, Endosee |
| Dysis Medical, INC. | $25.98 | 2020-2021 | |
| Channel Medsystems, INC. | $25.04 | 2023 | |
| Organon LLC | $20.11 | 2024 | |
| Duchesnay USA Incorporated | $18.70 | 2019 | |
| Roche Diagnostics Corporation | $18.53 | 2019 | |
| Lilly USA, LLC | $16.83 | 2024 | Zepbound |
| Aroa Biosurgery Incorporated | $16.68 | 2022 | |
| Avion Pharmaceuticals | $15.42 | 2023 | Balcoltra |
| Allergan, INC. | $13.76 | 2019 | |
| Asensus Surgical, INC. | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paulami Guha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.